Oyster Point Pharma Hits the Bulls EYE!
Oyster Point Pharma, Inc. (NASDAQ: OYST) is a commercial-stage biopharmaceutical company creating first-in-class therapies for the treatment of ophthalmic conditions. The Company’s lead product TYRVAYA, (varenicline solution) Nasal Spray 0.03 mg (formerly referred to as OC-01), has become the first and only FDA-approved nasal spray,...
